Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $100000.0.

  • Harvard Bioscience's Tax Provisions fell 6784.57% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $170000.0, marking a year-over-year decrease of 7966.51%. This contributed to the annual value of $740000.0 for FY2024, which is 1385.33% down from last year.
  • According to the latest figures from Q3 2025, Harvard Bioscience's Tax Provisions is $100000.0, which was down 6784.57% from $30000.0 recorded in Q2 2025.
  • Harvard Bioscience's 5-year Tax Provisions high stood at $1.3 million for Q4 2022, and its period low was -$1.3 million during Q3 2022.
  • For the 5-year period, Harvard Bioscience's Tax Provisions averaged around $133736.8, with its median value being $210000.0 (2024).
  • The largest annual percentage gain for Harvard Bioscience's Tax Provisions in the last 5 years was 55045.05% (2022), contrasted with its biggest fall of 82000.0% (2022).
  • Quarter analysis of 5 years shows Harvard Bioscience's Tax Provisions stood at $541000.0 in 2021, then soared by 135.12% to $1.3 million in 2022, then plummeted by 43.79% to $715000.0 in 2023, then decreased by 24.48% to $540000.0 in 2024, then crashed by 81.48% to $100000.0 in 2025.
  • Its Tax Provisions was $100000.0 in Q3 2025, compared to $30000.0 in Q2 2025 and -$500000.0 in Q1 2025.